Human antigen-specific T cell responses in viral control and immunopathology
Human antigen-specific T cell responses in viral control and immunopathology
批准号:
MR/Y015347/1
负责人:
Tao Dong
金额:
$180.04万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The main objective of my group is to investigate the functional aspects of antigen specific cytotoxic T cells (CTL) with a focus on the factors affecting CTL in controlling virus infection and cancer progression.While a robust and appropriate T cell response is typically beneficial to the host during human infections, a weak or inappropriate response can be ineffective or even have a detrimental effect. Over the past two decades, our efforts have been on understanding the key factors required for efficient viral control by T cells in a number of different viral infections and cancer. To do this, we have established an ex-vivo and in-vitro T cell functional evaluation platforms for antigen-specific T cells isolated from tissue and blood. By linking these functional data with multi-omic single cell and T cell receptor (TCR) repertoire analysis, we have identified potential targets and pathways to augment and control the immune response as a way of improving the outcome of several important human diseases including SARS-CoV-2 virus infection. In this proposal, we will address fundamental questions in CTL memory induction, central memory establishment and maintenance following virus infection and vaccination, with a particular focus on tissue-resident memory cells using SARS-CoV-2 as the model system. We aim to establish CTL functional relevance to efficient viral control and potential detrimental immunopathology in affected organs. By studying the immunology of tissues, we will provide scientific evidence and tools for improved vaccine design and therapeutic approaches for virus infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
[Monkey Pox] Rapid Research Response
-
批准号:BB/X011259/1
-
项目类别:Research Grant
-
资助金额:$21.84万
-
财政年份:2022
-
负责人:Tao Dong
-
依托单位:
Cellular immunity and genetic restriction of Influenza, Hepatitis C virus infection and Hepatitis B associated heptocellular carcinoma.
-
批准号:MC_UU_00008/11
-
项目类别:Intramural
-
资助金额:$188.2万
-
财政年份:2017
-
负责人:Tao Dong
-
依托单位:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
-
批准号:MR/L018942/1
-
项目类别:Research Grant
-
资助金额:$112.91万
-
财政年份:2014
-
负责人:Tao Dong
-
依托单位:
Virus specific memory T cell responses in H5N1 avian influenza virus infected patients
-
批准号:G1001046/1
-
项目类别:Research Grant
-
资助金额:$7.54万
-
财政年份:2010
-
负责人:Tao Dong
-
依托单位:
Virus specific memory T cell responses in H5N1 avian influenza virus infected patients
-
批准号:G0600520/1
-
项目类别:Research Grant
-
资助金额:$53.27万
-
财政年份:2006
-
负责人:Tao Dong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
COSMC/Tn antigen/mTOR 轴调控胃癌细胞转移的分子机制
研究
-
批准号:2024JJ9400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:赵娟霞
-
依托单位:
T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
-
批准号:81170386
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2011
-
负责人:赵鸿
-
依托单位:
新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
-
批准号:30801325
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:张争
-
依托单位:
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
-
批准号:30771999
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2007
-
负责人:王立新
-
依托单位:
Shp2 在polyomavirus middle T antigen(mT)诱发肿瘤过程中的作用
-
批准号:30700392
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2007
-
负责人:杨瑛
-
依托单位:
以Ag43为新型载体和佐剂的重组多价亚单位疫苗抗疟机理研究
-
批准号:30560160
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2005
-
负责人:谭光宏
-
依托单位:
Ag43/Fcε3嵌合细菌表面抗原蛋白疫苗抗I型变态反应研究
-
批准号:30460050
-
项目类别:地区科学基金项目
-
资助金额:19.0万元
-
批准年份:2004
-
负责人:谭光宏
-
依托单位: